| Product Code: ETC6735498 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China AIDS Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China AIDS Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China AIDS Treatment Market - Industry Life Cycle |
3.4 China AIDS Treatment Market - Porter's Five Forces |
3.5 China AIDS Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 China AIDS Treatment Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 China AIDS Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 China AIDS Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China AIDS Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 China AIDS Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 China AIDS Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and government initiatives to combat HIV/AIDS in China |
4.2.2 Rising prevalence of HIV/AIDS cases in China |
4.2.3 Technological advancements in AIDS treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment for approval of new AIDS treatment drugs |
4.3.2 High cost associated with AIDS treatment in China |
4.3.3 Stigma and discrimination surrounding HIV/AIDS in Chinese society |
5 China AIDS Treatment Market Trends |
6 China AIDS Treatment Market, By Types |
6.1 China AIDS Treatment Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 China AIDS Treatment Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 China AIDS Treatment Market Revenues & Volume, By HIV-1, 2021- 2031F |
6.1.4 China AIDS Treatment Market Revenues & Volume, By HIV-2, 2021- 2031F |
6.2 China AIDS Treatment Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 China AIDS Treatment Market Revenues & Volume, By Nucleoside/Nucleotide Reverse Transcriptase Inhibitors, 2021- 2031F |
6.2.3 China AIDS Treatment Market Revenues & Volume, By Non-Nucleoside Reverse Transcriptase Inhibitors, 2021- 2031F |
6.2.4 China AIDS Treatment Market Revenues & Volume, By Protease Inhibitors, 2021- 2031F |
6.2.5 China AIDS Treatment Market Revenues & Volume, By Fusion Inhibitors, 2021- 2031F |
6.2.6 China AIDS Treatment Market Revenues & Volume, By CCR5 Antagonist, 2021- 2031F |
6.2.7 China AIDS Treatment Market Revenues & Volume, By Integrase Inhibitors, 2021- 2031F |
6.2.8 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China AIDS Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 China AIDS Treatment Market Revenues & Volume, By Abacavir, 2021- 2031F |
6.3.3 China AIDS Treatment Market Revenues & Volume, By Delavirdine, 2021- 2031F |
6.3.4 China AIDS Treatment Market Revenues & Volume, By Atazanavir, 2021- 2031F |
6.3.5 China AIDS Treatment Market Revenues & Volume, By Enfuvirtide, 2021- 2031F |
6.3.6 China AIDS Treatment Market Revenues & Volume, By Maraviroc, 2021- 2031F |
6.3.7 China AIDS Treatment Market Revenues & Volume, By Dolutegravir, 2021- 2031F |
6.3.8 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3.9 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China AIDS Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China AIDS Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China AIDS Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.4 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China AIDS Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China AIDS Treatment Market Revenues & Volume, By Direct, 2021- 2031F |
6.5.3 China AIDS Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 China AIDS Treatment Market Revenues & Volume, By Retailers, 2021- 2031F |
6.5.5 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China AIDS Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China AIDS Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China AIDS Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 China AIDS Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 China AIDS Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China AIDS Treatment Market Import-Export Trade Statistics |
7.1 China AIDS Treatment Market Export to Major Countries |
7.2 China AIDS Treatment Market Imports from Major Countries |
8 China AIDS Treatment Market Key Performance Indicators |
8.1 Number of new HIV/AIDS cases diagnosed annually in China |
8.2 Percentage of HIV-positive individuals in China receiving antiretroviral therapy |
8.3 Funding allocation by the Chinese government for HIV/AIDS treatment and prevention |
8.4 Number of research and development projects focused on improving AIDS treatment options in China |
9 China AIDS Treatment Market - Opportunity Assessment |
9.1 China AIDS Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 China AIDS Treatment Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 China AIDS Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 China AIDS Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China AIDS Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 China AIDS Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 China AIDS Treatment Market - Competitive Landscape |
10.1 China AIDS Treatment Market Revenue Share, By Companies, 2024 |
10.2 China AIDS Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here